| Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib (NCT05263609) | University of Oklahoma | 2022-06-01 |
| A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland. (NCT05363072) | Pfizer | 2022-05-02 |
| Study of PF-07263689 in Participants With Selected Advanced Solid Tumors (NCT05061537) | Pfizer | 2021-10-20 |
| Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer (NCT04620603) | Case Comprehensive Cancer Center | 2021-05-27 |
| Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma (NCT04714697) | Asan Medical Center | 2021-03-01 |
| DNX-2440 for Resectable Colorectal Liver Metastasis (NCT04714983) | DNAtrix, Inc. | 2021-02-15 |
| WIRE - Novel Treatments in Renal Cell Cancer (NCT03741426) | CCTU- Cancer Theme | 2020-07-27 |
| Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma (NCT04260360) | NanOlogy, LLC | 2020-04-01 |
| Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA (NCT04197414) | Yonsei University | 2019-12-06 |
| Fear of Cancer Recurrence in Genitourinary Cancer (NCT04535921) | Ludwig-Maximilians - University of Munich | 2019-11-05 |
| Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase Inhibitors (NCT04040712) | Catholic University of the Sacred Heart | 2019-08-02 |
| Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors (NCT04258462) | Zhen Wang, MD | 2019-01-15 |
| CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers (NCT03454451) | Corvus Pharmaceuticals, Inc. | 2018-04-25 |
| Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer (NCT03455452) | Bristol-Myers Squibb | 2018-01-21 |
| Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers (NCT02830724) | National Cancer Institute (NCI) | 2017-04-06 |
| A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) (NCT02684006) | Pfizer | 2016-03-23 |
| Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers (NCT02655822) | Corvus Pharmaceuticals, Inc. | 2016-01-01 |
| ImmuniCell® in Patients With Advanced Cancers (NCT02459067) | TC Biopharm | 2015-12-01 |
| A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100) (NCT02493751) | Pfizer | 2015-10-26 |
| Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma (NCT02495103) | National Cancer Institute (NCI) | 2015-08-26 |
| Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib (NCT02428335) | AHS Cancer Control Alberta | 2015-06-01 |
| Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) (NCT02423954) | Western Regional Medical Center | 2015-04-01 |
| Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention (NCT02375776) | Massachusetts General Hospital | 2015-03-01 |
| A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031) (NCT02212730) | Merck Sharp & Dohme LLC | 2014-12-03 |
| IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy. (NCT01967407) | University of Magdeburg | 2013-10-01 |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer (NCT01631552) | Gilead Sciences | 2012-12-17 |
| Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients (NCT02071719) | M. Labots | 2012-04-01 |
| An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) (NCT01598597) | Genentech, Inc. | 2012-03-01 |
| Urine Proteome of Surgical Patients and Healthy Volunteers (NCT01538823) | Washington University School of Medicine | 2012-02-01 |
| Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients (NCT01402089) | Markus Joerger | 2012-01-01 |
| A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer (NCT01829841) | Jiangsu HengRui Medicine Co., Ltd. | 2011-05-01 |
| An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA) (NCT01392729) | Hoffmann-La Roche | 2010-09-01 |
| An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma (NCT01351571) | Hoffmann-La Roche | 2010-08-01 |
| Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) (NCT01122615) | M.D. Anderson Cancer Center | 2010-05-01 |
| Temsirolimus-RCC-imaging (NCT01246817) | Radboud University Medical Center | 2009-08-01 |
| Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients (NCT01507740) | Medical University Innsbruck | 2009-07-01 |
| Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib (NCT00890110) | Hadassah Medical Organization | 2009-06-01 |
| Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers (NCT01079286) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2009-06-01 |
| Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors (NCT00855452) | Hadassah Medical Organization | 2009-01-01 |
| A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC). (NCT00796757) | Hoffmann-La Roche | 2008-12-01 |
| Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma (NCT00509704) | Radboud University Medical Center | 2008-10-01 |
| Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer (NCT01189370) | University of Kansas Medical Center | 2008-06-01 |
| Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST (NCT00979329) | Radboud University Medical Center | 2008-05-01 |
| Bevacizumab in Metastatic Renal Cancer (NCT02627144) | Hoffmann-La Roche | 2008-01-01 |
| Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response (NCT00694096) | University of Utah | 2007-09-01 |
| A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. (NCT00520403) | Hoffmann-La Roche | 2007-09-01 |
| Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer (NCT00465179) | M.D. Anderson Cancer Center | 2007-03-01 |
| Percutaneous Tumor Ablation Vs Partial Nephrectomy for Small Renal Mass: the Impact of Histologic Variant and Tumor Size (NCT06829888) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2007-01-01 |
| Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer (NCT00304460) | National Cancer Institute (NCI) | 2006-03-13 |
| Relationship of Ochratoxin A to Upper Urologic Cancers (NCT00216801) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2005-09-01 |
| Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC) (NCT00184015) | University of Southern California | 2005-08-18 |
| Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides (NCT02429440) | University Hospital Tuebingen | 2005-05-01 |
| Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis (NCT00172003) | Novartis Pharmaceuticals | 2004-09-01 |
| A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy (NCT00738530) | Hoffmann-La Roche | 2004-06-01 |
| Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma (NCT00311467) | Central European Cooperative Oncology Group | 2004-03-01 |
| Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NCT00429026) | M.D. Anderson Cancer Center | 2004-01-01 |
| A Study of ABT-751 in Patients With Renal Cell Cancer (NCT00073112) | Abbott | 2003-08-01 |
| Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma (NCT00061178) | Genentech, Inc. | |